129 related articles for article (PubMed ID: 22783823)
1. Surface-modified gemcitabine with mucoadhesive polymer for oral delivery.
Lim JH; You SK; Baek JS; Hwang CJ; Na YG; Shin SC; Cho CW
J Microencapsul; 2012; 29(5):487-96. PubMed ID: 22783823
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine.
Lim JH; You SK; Baek JS; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2012; 7():2307-14. PubMed ID: 22661887
[TBL] [Abstract][Full Text] [Related]
3. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
[TBL] [Abstract][Full Text] [Related]
4. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations.
Yugatama A; Huang YL; Hsu MJ; Lin JP; Chao FC; Lam JKW; Hsieh CM
Int J Nanomedicine; 2024; 19():3753-3772. PubMed ID: 38686338
[TBL] [Abstract][Full Text] [Related]
5. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention.
Garg NK; Dwivedi P; Campbell C; Tyagi RK
Eur J Pharm Sci; 2012 Dec; 47(5):1006-14. PubMed ID: 23041219
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation.
Ventura CA; Cannavà C; Stancanelli R; Paolino D; Cosco D; La Mantia A; Pignatello R; Tommasini S
Biomed Microdevices; 2011 Oct; 13(5):799-807. PubMed ID: 21607718
[TBL] [Abstract][Full Text] [Related]
7. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of mucoadhesive polymer-coated nanoparticles.
Cui F; Qian F; Yin C
Int J Pharm; 2006 Jun; 316(1-2):154-61. PubMed ID: 16567070
[TBL] [Abstract][Full Text] [Related]
10. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
Joshi G; Kumar A; Sawant K
Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
[TBL] [Abstract][Full Text] [Related]
13. Role of chitosan nanoparticles in the oral absorption of Gemcitabine.
Derakhshandeh K; Fathi S
Int J Pharm; 2012 Nov; 437(1-2):172-7. PubMed ID: 22909993
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
Karavana SY; Şenyiğit ZA; Çalışkan Ç; Sevin G; Özdemir Dİ; Erzurumlu Y; Şen S; Baloğlu E
Drug Des Devel Ther; 2018; 12():1959-1975. PubMed ID: 29997433
[TBL] [Abstract][Full Text] [Related]
16. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system.
Arias JL; Reddy LH; Couvreur P
Biomacromolecules; 2011 Jan; 12(1):97-104. PubMed ID: 21117615
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
18. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
[TBL] [Abstract][Full Text] [Related]
19. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z
Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234
[TBL] [Abstract][Full Text] [Related]
20. Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes.
Celia C; Calvagno MG; Paolino D; Bulotta S; Ventura CA; Russo D; Fresta M
J Nanosci Nanotechnol; 2008 Apr; 8(4):2102-13. PubMed ID: 18572621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]